15 million COVID-19 vaccine doses wasted in U.S. since March 1
Sep 02, 2021
Reasons why doses may be marked as wasted include a cracked vial, an error diluting the vaccine or a freezer malfunction.
COVID-19 boosters could be in the arms of healthcare workers and seniors by early fall
By
Diane Eastabrook
Aug 17, 2021
Healthcare workers and older Americans would be among the first to receive COVID-19 boosters as early as fall, according to National Institutes of Health (NIH) Director Francis Collins, M.D.
Industry pursues two avenues for coronavirus relief as long-term care observes ‘most difficult year’
By
Kimberly Bonvissuto
Mar 03, 2021
American Health Care Association and National Center for Assisted Living President and CEO Mark Parkinson said the organizations are pursuing two avenues for coronavirus relief for operators since the...
In effort to boost COVID-19 vaccinations to homebound, CMS to pay $35 more per dose
By
Diane Eastabrook
Jun 09, 2021
The Centers for Medicare and Medicaid Services (CMS) announced Wednesday an additional payment for administering in-home COVID-19 vaccinations to Medicare beneficiaries having difficulty leaving their...
Moderna asks FDA to approve its booster shot for all adults
Nov 18, 2021
The Moderna booster is half the dose of the initial vaccination series: 50 mcg versus 100 mcg.
Pfizer asks FDA to approve booster shots for all U.S. adults
Nov 10, 2021
With its application, the company included early results of a study that involved 10,000 people.
White House calls out critics of door-to-door vaccine efforts
By
Diane Eastabrook
Jul 13, 2021
The Biden administration has come out swinging against governors and other state officials who have criticized the administration’s proposed door-to-door campaign to get Americans vaccinated.
Last week, the White House said local pharmacies are now providing more than two-thirds of COVID-19 vaccinations.
In 11 states, seniors’ low vaccination rates a ‘powder keg’ for new cases
Jun 21, 2021
In states where vaccination rates are low, seniors who have not gotten a shot pose a public health risk as social-distancing restrictions are stripped away.
Potential safety concern for Guillain-Barré syndrome ID’d for Ad26.COV2.S
Oct 18, 2021
Receipt of the Ad26.COV2.S (Janssen/Johnson & Johnson) COVID-19 vaccine is associated with a potential small, but statistically significant, safety concern for Guillain-Barré syndrome (GBS), according...